ACE2 and COVID-19: Further, based on a recent study57 that showed ACE2 and TMPRSS2 are expressed in prostate cells, it is conceivable that prostate may be a direct target of SARS-CoV-2 associated inflammation and adverse pathogenesis of COVID-19.